CATHERWOOD v ASTERON LIFE LIMITED [2023] NZCA 357

CATHERWOOD v ASTERON LIFE LIMITED [2023] NZCA 357

The phrase 'regardless of any available treatment' is ambiguous; on objective construction and commercial common sense, the definition of 'terminal illness' in the SmartLife policy must be read to permit consideration of available treatment when assessing life expectancy, and on that reading the insured did not meet...

Source-derived case information.

Citation
[2023] NZCA 357
Parties
Appellant: Hugh Roderick Catherwood; Respondent: Asteron Life Limited
Court
Court of Appeal
Jurisdiction
New Zealand
Judgment Date
9 August 2023
Procedural Posture
Civil Appeal (insurance) / Court of Appeal Determination on Appeal From High Court Judgment
Outcome
Appeal dismissed; High Court judgment upheld
Legal Topics
Interpretation of Terminal Illness Clause, Accelerated Death Benefit, Policy Construction, Contra Proferentem, Admissibility of Industry Practice Evidence
Insurance Law Contract Law Evidence Interpretation of Terminal Illness Clause Accelerated Death Benefit Policy Construction Contra Proferentem Admissibility of Industry Practice Evidence

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Legal principles 5 Authorities cited 8 Party arguments 2 Amounts and remedies 7
Sign in to unlock

Parties

Hugh Roderick Catherwood

Appellant

Asteron Life Limited

Respondent

Procedural Posture

Civil Appeal (insurance) / Court of Appeal Determination on Appeal From High Court Judgment

  1. 1 Whether the phrase 'regardless of any available treatment' in the policy's definition of 'terminal illness' requires ignoring available treatment or requires assessing prognosis taking available treatment into account
  2. 2 Whether insurer breached the policy by declining early payment of the sum insured
  3. 3 Admissibility and probative value of industry practice evidence on interpretation

Ratio Decidendi

The phrase 'regardless of any available treatment' is ambiguous; on objective construction and commercial common sense, the definition of 'terminal illness' in the SmartLife policy must be read to permit consideration of available treatment when assessing life expectancy, and on that reading the insured did not meet the terminal illness threshold; the insurer did not breach the policy and the appeal is dismissed.

Court Disposition

Appeal dismissed; High Court judgment upheld

Orders

  • Appellant must pay costs to respondent for a standard appeal on a band A basis with usual disbursements
  • Second counsel certified for respondent